BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9578057)

  • 1. Dose intensity in small cell lung cancer.
    Thatcher N; Lee SM; Woll PJ; Middleton M; Anderson H; Burt P; Stout R
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):12-8; discussion 45-8. PubMed ID: 9578057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of granulocyte-macrophage colony-stimulating factor in the treatment of germ cell tumors. German Testicular Cancer Study Group.
    Bokemeyer C; Harstrick A; Rüther U; Metzner B; Illiger HJ; Clemm C; Siegert W; Link H; Ostermann H; Schmoll HJ
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):57-63. PubMed ID: 7801148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte-macrophage colony-stimulating factor in the treatment of small cell lung cancer.
    Wolf M; Klausmann M; Havemann K
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):51-6. PubMed ID: 7801147
    [No Abstract]   [Full Text] [Related]  

  • 4. High-intensity chemotherapy with peripheral blood progenitor cell support.
    Fennelly D; Vahdat L; Schneider J; Reich L; Hamilton N; Hakes T; Raptis G; Wasserheit C; Kritz A; Gulati S
    Semin Oncol; 1994 Apr; 21(2 Suppl 2):21-5; quiz 26, 58. PubMed ID: 7515513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose chemo-radiotherapy cycles for LD small cell lung cancer patients using G-CSF and blood stem cells.
    Humblet Y; Bosquée L; Weynants P; Symann M
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S36-9. PubMed ID: 8899169
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in chemotherapy for lung cancer.
    Saijo N; Eguchi K; Etou H; Miyachi S; Morinari H; Nakada K; Noda K; Ohkuni Y; Watanabe K; Yamada Y
    Semin Oncol; 1994 Feb; 21(1 Suppl 1):54-8. PubMed ID: 7512277
    [No Abstract]   [Full Text] [Related]  

  • 7. [Peripheral blood stem cell harvest in patients with limited stage small-cell lung cancer].
    Katakami N; Takakura S; Fujii H; Nishimura T; Umeda B
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):865-71. PubMed ID: 10897213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential high-dose chemotherapy with autologous stem cell support in patients with limited-stage small cell lung cancer.
    Ziske C; Gorschlüter M; Mey U; Offergeld R; Glasmacher A; Schmidt-Wolf IG
    Anticancer Res; 2002; 22(6B):3723-6. PubMed ID: 12552983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer.
    Bessho A; Ueoka H; Kiura K; Tabata M; Sunami K; Katayama Y; Yamane H; Hiraki A; Harada M
    Anticancer Res; 1999; 19(1B):693-8. PubMed ID: 10216478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
    Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the clinical use of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor to intensify cancer chemotherapy.
    Fisher DC; Peters WP
    Curr Opin Hematol; 1994 May; 1(3):221-7. PubMed ID: 9371286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicyclic dose-intensive chemotherapy supported by autologous blood progenitor cell transplantation for relapsed small cell lung cancer.
    Fujimoto N; Ueoka H; Kiura K; Tabata M; Bessho A; Takata I; Sunami K; Hiramatsu Y; Ikeda K; Tanimoto M; Harada M
    Anticancer Res; 2003; 23(5b):4229-32. PubMed ID: 14666630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized phase III trial of dose-dense chemotherapy supported by whole-blood hematopoietic progenitors in better-prognosis small-cell lung cancer.
    Lorigan P; Woll PJ; O'Brien ME; Ashcroft LF; Sampson MR; Thatcher N
    J Natl Cancer Inst; 2005 May; 97(9):666-74. PubMed ID: 15870437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors: a report of the Children's Cancer Group.
    Cairo MS; Krailo MD; Weinthal JA; Secola R; Bergeron S; van de Ven C; Blazar BR; Garrison L; Reaman GH
    Cancer; 1998 Oct; 83(7):1449-60. PubMed ID: 9762948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral progenitor cells (PBPC) in supportive care after high-dose chemotherapy in breast cancer.
    Filip S; Bláha M; Petera J; Vavrová J; Knízek J
    Neoplasma; 2001; 48(1):39-47. PubMed ID: 11327536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escalating high-dose epirubicin plus cisplatin in small cell lung cancer with granulocyte-macrophage colony-stimulating factor use when appropriate.
    Rosell R; Gómez-Codina J; Anton A; Sánchez JJ; Vadell C
    Semin Oncol; 1994 Feb; 21(1 Suppl 1):48-53. PubMed ID: 8153657
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recent issue in the treatment of small-cell lung cancer].
    Ueoka H; Hiraki S
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1665-70. PubMed ID: 9757190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter randomized open-label phase III study comparing efficacy, safety, and tolerability of conventional carboplatin plus etoposide versus dose-intensified carboplatin plus etoposide plus lenograstim in small-cell lung cancer in "extensive disease" stage.
    Heigener DF; Manegold C; Jäger E; Saal JG; Zuna I; Gatzemeier U
    Am J Clin Oncol; 2009 Feb; 32(1):61-4. PubMed ID: 19194127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials referral resource. Small-cell lung cancer.
    Cheson BD
    Oncology (Williston Park); 1990 Jan; 4(1):43-56. PubMed ID: 2168198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.